Pilotto A et al. |
Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients. |
1999 |
J. Gastroenterol. Hepatol. |
pmid:10355512
|
Jacoby EB and Porter KB |
Helicobacter pylori infection and persistent hyperemesis gravidarum. |
1999 |
Am J Perinatol |
pmid:10355915
|
Fost DA et al. |
Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy. |
1999 |
J. Allergy Clin. Immunol. |
pmid:10359882
|
Gooch WM et al. |
Loracarbef versus clarithromycin in children with acute otitis media with effusion. |
1999 |
Clin Ther |
pmid:10363736
|
Moshkowitz M et al. |
The efficacy of omeprazole-based short-term triple therapy in Helicobacter pylori-positive older patients with dyspepsia. |
1999 |
J Am Geriatr Soc |
pmid:10366173
|
Wimsatt JH et al. |
Clarithromycin pharmacokinetics in the desert tortoise (Gopherus agassizii). |
1999 |
J. Zoo Wildl. Med. |
pmid:10367642
|
Iida H et al. |
Hypoglycemia induced by interaction between clarithromycin and disopyramide. |
1999 |
Jpn Heart J |
pmid:10370402
|
Bhasin DK et al. |
Helicobacter pylori eradication: comparison of three treatment regimens in India. |
1999 |
J. Clin. Gastroenterol. |
pmid:10372934
|
Behrens R et al. |
Dual versus triple therapy of Helicobacter pylori infection: results of a multicentre trial. |
1999 |
Arch. Dis. Child. |
pmid:10373140
|
Masa K et al. |
Effect of clarithromycin and other macrolides on the sulfoxidation and 5-hydroxylation of lansoprazole in dogs. |
1999 |
Biol. Pharm. Bull. |
pmid:10375172
|
Bamford JT et al. |
Effect of treatment of Helicobacter pylori infection on rosacea. |
1999 |
Arch Dermatol |
pmid:10376693
|
Alvarez-Elcoro S and Enzler MJ |
The macrolides: erythromycin, clarithromycin, and azithromycin. |
1999 |
Mayo Clin. Proc. |
pmid:10377939
|
Vakil N |
Treatment of H. pylori infection: the reality. |
1998 Mar-Apr |
Yale J Biol Med |
pmid:10378357
|
Delle Cave M et al. |
Seven days of ranitidine bismuth citrate plus two antimicrobials for Helicobacter pylori eradication. |
1999 |
Ital J Gastroenterol Hepatol |
pmid:10379492
|
Schubert ML |
H. pylori and nonulcer dyspepsia: not guilty as charged. |
1999 |
Gastroenterology |
pmid:10381939
|
Realdi G et al. |
Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies. |
1999 |
Helicobacter |
pmid:10382124
|
Schwartz HI et al. |
Twice-daily versus thrice-daily clarithromycin in combination with ranitidine bismuth citrate in the eradication of Helicobacter pylori. |
1999 |
Helicobacter |
pmid:10382126
|
Hoellman DB et al. |
Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents. |
1999 |
J. Antimicrob. Chemother. |
pmid:10382885
|
Steele-Moore L et al. |
In vitro activities of clarithromycin and azithromycin against clinical isolates of Mycobacterium avium-M. intracellulare. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10383373
|
Huang J and Hunt RH |
The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383500
|
Miwa H et al. |
Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383502
|
Ducóns JA et al. |
Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383507
|
Calvet X et al. |
Two-week dual vs. one-week triple therapy for cure of Helicobacter pylori infection in primary care: a multicentre, randomized trial. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383508
|
Sieg A et al. |
Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383519
|
Grimley CE et al. |
Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383520
|
Houben MH et al. |
Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383522
|
Tomiyama Y et al. |
[The combination therapy of clarithromycin and sparfloxacin for pulmonary Mycobacterium gordonae infection]. |
1999 |
Kekkaku |
pmid:10386036
|
Stewart AK et al. |
Lack of response to short-term use of clarithromycin (BIAXIN) in multiple myeloma. |
1999 |
Blood |
pmid:10391696
|
Raderer M et al. |
Successful symptomatic management of a patient with Ménétrier's disease with long-term antibiotic treatment. |
1999 Jul-Aug |
Digestion |
pmid:10394031
|
Tsukamoto T et al. |
Biofilm in complicated urinary tract infection. |
1999 |
Int. J. Antimicrob. Agents |
pmid:10394976
|
Hafner R et al. |
Correlation of quantitative bone marrow and blood cultures in AIDS patients with disseminated Mycobacterium avium complex infection. |
1999 |
J. Infect. Dis. |
pmid:10395860
|
Inoue M et al. |
[Susceptibilities of Enterococcus faecium, PRSP and MRSA to RP59500 and their correlations with those to other drugs]. |
1999 |
Jpn J Antibiot |
pmid:10396687
|
Lasko B et al. |
Efficacy and safety of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: a multicentre, double-blind, randomized study. The Canadian Sinusitis Study Group. |
1998 |
J. Int. Med. Res. |
pmid:10399110
|
Horgan SE et al. |
Use of a low nutrient culture medium for the identification of bacteria causing severe ocular infection. |
1999 |
J. Med. Microbiol. |
pmid:10403423
|
Mera R et al. |
Eradication of Helicobacter pylori infection with proton pump-based triple therapy in patients in whom bismuth-based triple therapy failed. |
1999 |
J. Clin. Gastroenterol. |
pmid:10405232
|
Katsura Y et al. |
Anti-Helicobacter pylori agents. 3. 2-[(Arylalkyl)guanidino]-4-furylthiazoles. |
1999 |
J. Med. Chem. |
pmid:10425101
|
Grimm KJ |
Treatment of Helicobacter pylori infection in functional dyspepsia. |
1999 |
J Fam Pract |
pmid:10428242
|
Johnson MM et al. |
Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10428903
|
Credito KL et al. |
Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10428930
|
Kyzekova J and Mour J |
The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study. |
1999 May-Jun |
Hepatogastroenterology |
pmid:10430396
|
Owen RJ et al. |
Effect of clarithromycin and omeprazole therapy on the diversity and stability of genotypes of Helicobacter pylori from duodenal ulcer patients. |
1999 |
Microb. Drug Resist. |
pmid:10432275
|
Baena DÃez JM et al. |
[Are 5 days of omeprazole plus 2 antibiotics enough for eradication of H. pylori? Comments on sample size]. |
1999 |
Rev Clin Esp |
pmid:10432821
|
Schmitt H et al. |
Successful treatment of pulmonary Mycobacterium xenopi infection in a natural killer cell-deficient patient with clarithromycin, rifabutin, and sparfloxacin. |
1999 |
Clin. Infect. Dis. |
pmid:10433574
|
Cohn DL et al. |
A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS. |
1999 |
Clin. Infect. Dis. |
pmid:10433575
|
Lipsky BA et al. |
Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin. |
1999 |
Clin Ther |
pmid:10440620
|
Shimada N et al. |
[A case of acute renal failure with rhabdomyolysis caused by the interaction of theophylline and clarithromycin]. |
1999 |
Nihon Jinzo Gakkai Shi |
pmid:10441997
|
Bazzoli F |
My approach to Helicobacter pylori eradication. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10443911
|
Ali' A et al. |
A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment. |
1999 |
Am. J. Gastroenterol. |
pmid:10445583
|
Hewitt RG et al. |
Prevention of disseminated Mycobacterium avium complex infection with reduced dose clarithromycin in patients with advanced HIV disease. |
1999 |
AIDS |
pmid:10449290
|
Enroth H et al. |
Occurence of resistance mutation and clonal expansion in Helicobacter pylori multiple-strain infection: a potential risk in clarithromycin-based therapy. |
1999 |
Clin. Infect. Dis. |
pmid:10451171
|
Anzueto A et al. |
The infection-free interval: its use in evaluating antimicrobial treatment of acute exacerbation of chronic bronchitis. |
1999 |
Clin. Infect. Dis. |
pmid:10451195
|
Gordin FM et al. |
A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex. |
1999 |
Clin. Infect. Dis. |
pmid:10452638
|
Pandita D and Carson PJ |
Thyroid abscess caused by Mycobacterium chelonae. |
1999 |
Clin. Infect. Dis. |
pmid:10452671
|
Härtig G et al. |
[Symptomatic psychosis in bland sinus thrombosis and antibiotic therapy]. |
1999 |
Psychiatr Prax |
pmid:10457975
|
Labenz J and Stolte M |
[Is lack of stomach carcinoma prevention by Helicobacter pylori eradication unethical?]. |
1999 |
Z Gastroenterol |
pmid:10458014
|
Boyanova L et al. |
Characteristics and trends in macrolide resistance among Helicobacter pylori strains isolated in Bulgaria over four years. |
1999 |
Diagn. Microbiol. Infect. Dis. |
pmid:10459482
|
Sendi PP et al. |
Systematic validation of disease models for pharmacoeconomic evaluations. Swiss HIV Cohort Study. |
1999 |
J Eval Clin Pract |
pmid:10461580
|
Gooderham MJ et al. |
Concomitant digoxin toxicity and warfarin interaction in a patient receiving clarithromycin. |
1999 Jul-Aug |
Ann Pharmacother |
pmid:10466907
|
Gschwantler M et al. |
Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori--a randomized, controlled trial. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10468682
|
Paré P et al. |
Comparison of ranitidine bismuth citrate plus clarithromycin with omeprazole plus clarithromycin for the eradication of Helicobacter pylori. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10468683
|
Sung JJ et al. |
One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10468684
|
Catalano F et al. |
Comparative treatment of Helicobacter pylori-positive duodenal ulcer using pantoprazole at low and high doses versus omeprazole in triple therapy. |
1999 |
Helicobacter |
pmid:10469192
|
Kamada T et al. |
Effect of smoking and histological gastritis severity on the rate of H. pylori eradication with omeprazole, amoxicillin, and clarithromycin. |
1999 |
Helicobacter |
pmid:10469195
|
Bui KQ et al. |
Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10471584
|
Tanaka E et al. |
Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease. |
1999 |
Am. J. Respir. Crit. Care Med. |
pmid:10471610
|
Mikamo H et al. |
Adequate macrolide treatment schedules for uterine cervicitis caused by Chlamydia trachomatis. |
1999 Sep-Oct |
Chemotherapy |
pmid:10473928
|
Geiderman JM |
Central nervous system disturbances following clarithromycin ingestion. |
1999 |
Clin. Infect. Dis. |
pmid:10476775
|
Gómez Cubillos C et al. |
[Can macrolide treatment delay the diagnosis of tuberculosis?]. |
1999 |
An Med Interna |
pmid:10481348
|
Sato K et al. |
[MICs and MBCs of levofloxacin, clarithromycin, and KRM-1648 for Mycobacterium tuberculosis and M. avium complex residing in MONO-MAC-6 human macrophage-like cell and A-549 human type II alveolar epithelial cell lines]. |
1999 |
Kekkaku |
pmid:10481412
|
Gidoh M |
[The control leprous peripheral neuropathy and chemotherapy]. |
1999 |
Nihon Hansenbyo Gakkai Zasshi |
pmid:10481449
|
Klapper SR and Patrinely JR |
Periocular atypical mycobacterial infections. |
1999 |
Ophthalmology |
pmid:10485521
|
Matsuoka M et al. |
Simultaneous colonisation of Helicobacter pylori with and without mutations in the 23S rRNA gene in patients with no history of clarithromycin exposure. |
1999 |
Gut |
pmid:10486356
|
Tyagi AK et al. |
An unreported side effect of topical clarithromycin when used successfully to treat Mycobacterium avium-intracellulare keratitis. |
1999 |
Cornea |
pmid:10487437
|
RodrÃguez Téllez M et al. |
Morphometric estimation of acid output in duodenal ulcer associated with Helicobacter pylori infection. |
1999 |
Rev Esp Enferm Dig |
pmid:10491487
|
Gutiérrez-Cabano CA and Raynald AC |
Gastroprotective effect of intragastric clarithromycin against damage induced by ethanol in rats. |
1999 |
Dig. Dis. Sci. |
pmid:10492159
|
Moore PA |
Dental therapeutic indications for the newer long-acting macrolide antibiotics. |
1999 |
J Am Dent Assoc |
pmid:10492541
|
Osato MS et al. |
Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States. |
1999 |
Int. J. Antimicrob. Agents |
pmid:10493611
|
Hirsh DC and Jang SS |
Antimicrobial susceptibility of Nocardia nova isolated from five cats with nocardiosis. |
1999 |
J. Am. Vet. Med. Assoc. |
pmid:10496134
|
Ellenrieder V et al. |
Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication. |
1999 |
Scand. J. Gastroenterol. |
pmid:10499474
|
Zgoulli S et al. |
Microencapsulation of erythromycin and clarithromycin using a spray-drying technique. |
1999 Sep-Oct |
J Microencapsul |
pmid:10499837
|
Landesman KA et al. |
Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics. |
1999 |
Conn Med |
pmid:10500341
|
Gómez G et al. |
Acute tacrolimus nephrotoxicity in renal transplant patients treated with clarithromycin. |
1999 |
Transplant. Proc. |
pmid:10500563
|
Unge P |
The OAC and OMC options. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503817
|
Spiller RC |
Is there any difference in Helicobacter pylori eradication rates in patients with active peptic ulcer, inactive peptic ulcer and functional dyspepsia? |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503819
|
Mégraud F |
Resistance of Helicobacter pylori to antibiotics: the main limitation of current proton-pump inhibitor triple therapy. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503821
|
Bazzoli F et al. |
What can be learnt from the new data about antibiotic resistance? Are there any practical clinical consequences of Helicobacter pylori antibiotic resistance? |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503822
|
Gisbert JP et al. |
Re-treatment after Helicobacter pylori eradication failure. |
1999 |
Eur J Gastroenterol Hepatol |
pmid:10503846
|
Uygun A et al. |
Efficacy of omeprazole plus two antimicrobials for the eradication of Helicobacter pylori in a Turkish population. |
1999 |
Clin Ther |
pmid:10509849
|
McMullin ST et al. |
Impact of a Web-based clinical information system on cisapride drug interactions and patient safety. |
1999 |
Arch. Intern. Med. |
pmid:10510994
|
Furuta T et al. |
Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans. |
1999 |
Clin. Pharmacol. Ther. |
pmid:10511062
|
Galil K et al. |
Abscesses due to mycobacterium abscessus linked to injection of unapproved alternative medication. |
1999 Sep-Oct |
Emerging Infect. Dis. |
pmid:10511524
|
Talley NJ et al. |
Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. |
1999 |
N. Engl. J. Med. |
pmid:10511608
|
Gilljam M et al. |
Therapeutic drug monitoring in patients with cystic fibrosis and mycobacterial disease. |
1999 |
Eur. Respir. J. |
pmid:10515412
|
Rovira E et al. |
Treatment of community-acquired pneumonia in outpatients: randomized study of clarithromycin alone versus clarithromycin and cefuroxime. |
1999 |
Respiration |
pmid:10516537
|
Foster SF et al. |
Chronic pneumonia caused by Mycobacterium thermoresistibile in a cat. |
1999 |
J Small Anim Pract |
pmid:10516950
|
Goldberg EI et al. |
Henoch-Schönlein purpura induced by clarithromycin. |
1999 |
Int. J. Dermatol. |
pmid:10517691
|
Uygun A et al. |
Low efficacy of ranitidine bismuth citrate plus clarithromycin combination on Helicobacter pylori in a Turkish population. |
1999 |
Am. J. Gastroenterol. |
pmid:10520880
|
Gibson JR et al. |
Novel method for rapid determination of clarithromycin sensitivity in Helicobacter pylori. |
1999 |
J. Clin. Microbiol. |
pmid:10523591
|
Baylor P and Williams K |
Interstitial nephritis, thrombocytopenia, hepatitis, and elevated serum amylase levels in a patient receiving clarithromycin therapy. |
1999 |
Clin. Infect. Dis. |
pmid:10525003
|
Yoh M et al. |
Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7. |
1999 |
Can. J. Microbiol. |
pmid:10526400
|